References
- Sjoerdsma A, Golden J A, Schechter P J, et al. Successful treatment of lethal protozoal infections with the ornithine decarboxylase inhibitor, alpha-difluoromethyl-ornithine. Trans Assoc Am Physicians 1984; 97: 70–79
- Fozard J R, Part M L, Prakash N J, et al. L. ornithine decarboxylase: An essential role in early mammalian embryogenesis. Science 1980; 208: 505–508
- Bartolome J V, Schweitzer L, Slotkin T A, et al. Impaired development of cerebellar cortex in rats treated postnatally with alpha-difluoromethylornithine. Neuroscience 1985; 15: 203–213
- Homma Y, Ozono S, Numata I, et al. Inhibition of carcinogenesis by alpha-difluoromethylornithine in heterotopically transplanted rat urinary bladders. Cancer Res 1985; 45: 648–652
- Khot S N, Bajpai P K, Graves G A, et al (1980) Ceramic materials for delivering polypeptide hormone. Proceedings of the Eighth Annual Northeast Bioengineering Conference, New York, March, 27–281980. Pergamon, New York, 16–21, MIT, Cambridge, MA
- Benghuzzi H A, Bajpai P K. Sustained delivery of steroids and proteins in human plasma by means of Alcap delivery system. Fed Proc 1987; 46: 809
- Bajpai P K. Alcap ceramics in drug delivery. Invited paper presented at the Symposium on Polymers for Biomedical Applications. 1985; 2: 203, ACS Polym Preprints 26
- Bajpai P K, Anderson J J, Benghuzzi H A. Drug delivery by ceramics and composites. International Symposium on Artificial Organs, Biomedical Engineering and Transplantation, Salt Lake City, UT, Jan, 20–231986, 34
- Al-Arabi A, Mattie D R, Bajpai P K (1982) Use of alumino-calcium-phosphorous oxide (ALCAP) ceramics for delivering polypeptides of varying molecular weights. Proceedings of the 10th Northeast Bioengineering Conference, Dartmouth University, Hanover, NH, Mar, 15–161982. IEEE, New York, 90–93
- Benghuzzi H A, Bajpai P K. The delivery of progesterone, estradiol, and 5-alpha, androstan-3, 17-dione combinations from ALCAP ceramic capsules. Proceedings of the Sixth Southern Biomedical Engineering Conference, Dallas, TX, Oct, 23–241987, 134–137
- Benghuzzi H A, Bajpai P K. The delivery of danazol, dihydrotestosterone and testosterone combinations from Alcap ceramic capsules. Paper presented at the 13th Annual Meeting of the Society for Biomaterials, New York, June, 3–71987, 214
- Anderson J J, Bajpai P K (1987) Maintenance of adrenalectomized rats by corticoids delivered from a sustained release ceramic device. 13th North East Bioengineering Conference, Philadelphia, PA, Mar, 12–131987, K Foster. IEEE, New York, 2: 557–560
- Benghuzzi H A, Bajpai P K. A polymer impregnated ALCAP ceramic system for delivering danazol. Clin Res 1986; 34: 962A
- Benghuzzi H A, Bajpai P K (1986) Effect of polylactic acid impregnation and variation of aqueous ethanol concentration on the in vitro delivery of testosterone by Alcap ceramics. Biomedical Engineering V Recent Developments. Proceedings of the Fifth Southern Biomedical Engineering Conference, Shreveport, LA, Oct, 24–251986, S Saha. Pergamon, New York, 482–485
- Benghuzzi H A, Bajpai P K. Effect of compression loads on delivery of steroids (testosterone) from Alcap ceramics. Fed Proc 1986; 43: 171
- McGuire M A, Bajpai P K. In vitro delivery of testosterone by ALCAP ceramics. Physiologist 1984; 27: 242
- Strasser J, Bajpai P K (1985) Polymer impregnated ALCAP ceramics: Delivery of gossypol acetic acid. Proceedings of the 11th Northeast Bioengineering Conference, Worcester, MA, Mar, 14–151985. IEEE, New York, 166–169
- McFall F B, Bajpai P K (1984) Effect of resorbable alumino-calcium-phosphorous-oxide (ALCAP) ceramic implant in rats. Paper presented at the Second World Congress on Biomaterials and 10th Annual Meetings of the Society for Biomaterials, Washington, DC, Apr-May, 27-11984, 7, 354, Transactions of the 10th Annual Meeting of the Society for Biomaterials
- Benghuzzi H A, Bajpai P K. Sustained delivery of difluoromethylornithine (DFMO) by alumino-calcium-phosphorous oxide ceramic capsules. Clin Res 1986; 34: 421A
- Moore S, Stein W H. A modified ninhydrin reagent for the photometric determination of amino acids and related compounds. J Biol Chem 1954; 211: 907–913
- Van Nieuwenhove S, Schechter P J, Declerco J, et al. Treatment of gambiense sleeping sickness in the Sudan with oral DFMO (DL-difluoromethylornithine), an inhibitor of ornithine decarboxylase; first field trial. Trans R Soc Tropical Med Hygiene 1985; 79: 692–698